Related Experiment Video
Updated: Aug 5, 2026
07:16
Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Understanding Benzodiazepines: Therapeutic Roles, Risks, and Real-World Trends
Stephanie Widmer1, Alexandros Prokopiou2, Nicole Lipman2
1Emergency Medicine Residency, Department of Emergency Medicine, St. John's Riverside Hospital, Yonkers, NY 10701, USA.
Primary Care
|July 28, 2026
Summary
Benzodiazepines are common medications for anxiety and insomnia but pose significant misuse risks, especially with opioids. This review covers their history, effects, and factors driving misuse, highlighting public health concerns.
Area of Science:
- Pharmacology
- Public Health
- Epidemiology
Background:
- Benzodiazepines are widely prescribed for anxiety, seizures, insomnia, and sedation.
- Despite therapeutic benefits, benzodiazepine misuse presents a growing public health concern.
- Concurrent use with central nervous system depressants like opioids increases risks.
Purpose of the Study:
- To review the clinical utility and public health concerns of benzodiazepines.
- To examine the history and mechanism of action of benzodiazepines.
- To explore epidemiological data, demographic factors, and drivers of benzodiazepine misuse, including overprescription.
Main Methods:
- Literature review of benzodiazepine history and pharmacology.
- Analysis of current epidemiological data on benzodiazepine misuse in the US.
- Exploration of psychiatric and other factors contributing to misuse.
Main Results:
- Benzodiazepine misuse is a significant issue, particularly when combined with other substances.
- Overprescription and specific demographic factors are associated with misuse.
- Understanding the drivers of misuse is crucial for public health interventions.
Conclusions:
- Benzodiazepines require careful clinical management due to misuse potential.
- Public health strategies must address the multifaceted drivers of benzodiazepine misuse.
- Further research into effective interventions for benzodiazepine misuse is warranted.
Related Concept Videos
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
01:26Anxiolytic Drugs: Overview
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
01:14CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
01:23Sedatives and Hypnotics: Overview
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
01:20Sedatives and Hypnotics Drugs: Barbiturates
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...